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The purpose of the INTERGROWTH-21st project was to develop international, prescriptive standards for fetal growth assessed by ultrasound and fundal
height, preterm postnatal growth, newborn size and body composition, maternal weight gain, and infant development at the age of 2 years. Hence, we
have produced, based on World Health Organization recommendations, the first comprehensive set of international standards of optimal fetal and
newborn growth that perfectly match the existing World Health Organization child growth standards. Uniquely, the same population was followed up
longitudinally from 9 weeks of fetal life to 2 years of age, with growth, health, and nutritional status assessment at 2 years supporting the appro-
priateness of the population for construction of growth standards. The resulting package of clinical tools allows, for the first time, growth and
development to bemonitored from early pregnancy to infancy. The INTERGROWTH-21st fetal growth standards, which are based on observing>4500
healthy pregnancies, nested in a study of>59,000 pregnancies from populations with low rates of adverse perinatal outcomes, show how fetuses
should growerather than the more limited objective of past references, which describe how they have grown at specific times and locations. Our work
has confirmed the fundamental biological principle that variation in human growth across different populations is mostly dependent on environmental,
nutritional, and socioeconomic factors. We found that whenmothers’ nutritional and health needs aremet and there are few environmental constraints
on growth,<3.5% of the total variability of skeletal growth was due to differences between populations. We propose that not recognizing the concept
of optimal growth could deprive the most vulnerable mothers and their babies of optimal care, because local growth charts normalize those at highest
risk for growth restriction and overweight, and can be valuable for policymakers to ensure rigorous evaluation and effective resource allocation. We
strongly encourage colleagues to join efforts to provide integrated, evidence-based growthmonitoring to pregnant women and their infants worldwide.
Presently, there are 23.3 million infants born small for gestational age in low- to middle-income countries according to the INTERGROWTH-21st
newborn size standards. We suggest that misclassification of these infants by using local charts could affect the delivery of optimal health care.
Key words: abdominal circumference, biparietal diameter, estimated fetal weight, femur length, fetal size, macrosomia, optimal growth,
reference chart, skeletal growth, small for gestational age, socioeconomic status, standard, stunting
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Recent publications1-5 and ensuing
editorials and correspondence,6-9 as well
as presentations and debates at national
and international meetings, have acti-
vated a controversy that goes well
beyond the boundaries of obstetrics and
perinatal medicine. The controversies
touch upon fundamental topics in
biology, genetics, politics, and human
rights. Sadly, some arguments have at
times been reminiscent of the historical
dispute about the influence of race or
ethnicity or on human head size and
shape.10
There is little disagreement about the
similarity of human growth across
healthy populations in early pregnancy,
and the applicability of international
standards to estimate gestational age,2,11
evaluate size at birth worldwide,12-14 and
monitor the growth of term newborns
up to 5 years of age.15 However, chal-
lenges are being made to key conceptual
and factual issues relating to fetal growth
monitoring in the second half of
pregnancy that are preventing the
introduction of integrated care across
the first 1000 days of life.
Some members of the obstetric com-
munity seem to hold firmly to the view
that fetal growth differences among
healthy populations, specifically >14
weeks’ gestation, are strongly influenced
by maternal factors such as self-reported
ethnicity, nationality, or political bor-
ders. This position is difficult to sustain
given the strong evidence, obtained from
detailed monitoring of low-risk cohorts
from early pregnancy to 2 years of age,
that human growth, evaluated by
markers of skeletal, fat-free mass (ie,
fetal crown-rump length [CRL] and
head circumference [HC], birth length,
HC at birth, and infant length), is very
similar among low-risk populations
regardless of where they live, or their
race/ethnicity,16,17 as demonstrated
more than a decade ago by the World
Health Organization (WHO) Multi-
center Growth Reference Study
(MGRS).18
Differences observed in perinatal
health among general populations across
countries are principally due to the
downstream effects of environmental,nutritional, and socioeconomic
factorsefrequently across generationse
and this has important consequences.
These are well recognized in medicine
and public health, ie, a mother’s ZIP
code is a better indicator of her health
status than her genetic code.19,20 Our
aim here, therefore, is to dispel these
misconceptions and unsubstantiated
beliefs that, if left uncorrected, could
adversely affect the quality of care
offered to women and their families.
Methodological issues relevant for
the screening of fetal growth
abnormalities in the general pregnant
population
References vs standards
At present, clinicians around the world
are using many different ultrasound
charts of fetal size, based on a variety of
populations and methodologies, to
monitor growth. However, in a series of
systematic reviews, we have shown that
the majority of these charts were devel-
oped with important methodological
flaws.21-23
All these charts are references rather
than prescriptive standards. The
distinction is critical. References
describe how individuals have grown at a
particular time and place, often decades
beforehand. Prescriptive standards, on
the other hand, are purposely developed
using a selected, healthy population, to
describe how humans should grow when
nutritional, environmental, and health
constraints on growth areminimal. They
are based conceptually on the WHO
1995 recommendation that “human
growth should be evaluated using inter-
national standards, describing how in-
dividuals should grow.”24 Of course,
results from any screening test, so also in
the case of growth monitoring using a
standard, then require clinical judge-
ment to interpret findings and deter-
mine future actions.
The use of references instead of
standards has important implications at
individual and populations levels that
impact clinical care and public health
policies. To understand why, it is
important to realize that the distribution
of size in the general population does not
constitute a standard. The prevalence ofFEBRUARY 2018 Amstunting among children globally illus-
trates the point well, as the rate of
stunting is inversely related to the level of
socioeconomic status (SES).25 There-
fore, size charts based on the distribution
of biometric measures in low and high
SES populations will be very different
from each other. A chart based on a low
SES sample will clearly underestimate
the prevalence of small for gestational
age (SGA) and stunting, which are
markers of social inequity.25
These differences can be illustrated
when assessing the INTERGROWTH-
21st project and the WHO-sponsored
study by Kiserud et al,4 which had
completely different objectives. The
former was a comprehensive evaluation
of human growth and development
across the first 1000 days of life, leading
to the construction of fetal and preterm
postnatal growth standards; it included
an assessment of newborn body
composition, infant feeding practices,
and preterm postnatal growth, as
well as postnatal growth and neuro-
development evaluation at 2 years of
age to assess the appropriateness
of the complete cohort for the con-
struction of standards (Panel 1). The
INTERGROWTH-21st project26 also
adhered rigorously to the WHO recom-
mendations for assessing human size
and growth (see below).24 In contrast,
theWHO-sponsored study was hospital-
based, and generated fetal growth refer-
ences not standards4; the selection of the
population to study, outcome measures,
ultrasound equipment, and analytical
strategy were different, as indeed was the
lack of masking the ultrasound measures
to avoid potential observer bias.
This need to differentiate standards
from reference charts is not an obscure
intellectual matter but a vitally impor-
tant global issue with marked political
and socioeconomic ramifications. How
else can progress toward United Nations
Sustainable Developmental Goal 3.1
(end preventable deaths of newborns
and children <5 years of age) be
measured, unless international stan-
dards are used to compare the health and
nutritional status of infants, as was done
in assessing progress towardMillennium
Development Goal 1 (eradicate extremeerican Journal of Obstetrics& Gynecology S631
PANEL 1
INTERGROWTH-21st project characteristics
Large prospective study of 59,137 pregnant women
Population based: all institutions providing pregnancy and delivery care in 8 geographically
limited urban areas with low rates of adverse perinatal outcomes and low pollution, domestic
smoke, radiation, and other toxic substances
Sampling of individual women within 8 geographic areas using predefined criteria for
construction of standards
Participants followed up to age 2 y
Pregnancy, neonatal anthropometry, and perinatal conditions recorded for total population
(59,137 pregnant women) in 8 geographic areas using standardized procedures, identical
equipment, and centrally trained staff
Environmental conditions evaluated using special data collection form developed in
collaboration with Center for Environmental Research and Children’s Health, University of
California, following WHO recommendations
Excluded from standards only severe maternal or fetal conditions defined a priori
A priori data analysis plan based on WHO recommendations to construct human growth
standards
Use of skeletal growth measures from <14 wk’ gestation to age 2 y for comparisons across
populations, as recommended by WHO
Three complementary data analysis strategies to support pooling data for construction of
standards
International standards for human growth from <14 wk’ gestation to age 2 y
International preterm postnatal growth standards as recommended by WHO
Preterm postnatal motor development assessment following WHO milestones
Published real-time, online data management system
Ultrasound equipment selected based on predefined criteria after extensive public consultation
according to WHO administrative requirements
Ultrasound measures in triplicate and corroborated by newborn anthropometry
Ultrasound results masked to operators to eliminate expected result bias
Standardized equipment at all sites for ultrasound; maternal, newborn, and child
anthropometry
Ultrasound machines calibrated with standard phantom
Published system of:
 Training, standardization, and certification of ultrasound operators
 Quality-control strategy for all maternal and postnatal measures
 Assessment of intraobserver and interobserver variation of ultrasound fetal biometry
 Protocols for quality control of ultrasound image review, data monitoring, and random
sample remeasurement
WHO, World Health Organization.
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in stunting rates based on the interna-
tional WHO child growth standards?27
Making late fetal growth charts
country- or region-specific would not
only make this task impossible, it risks
confusing the interpretation of all other
growth and health indicators across
populations.
How were the INTERGROWTH-21st
populations selected?
The first step in creating prescriptive
international standards of optimal fetal
growth was to select free-living pop-
ulations in defined geographic areas with
minimal constraints on growth, andS632 American Journal of Obstetrics& Gynecologgood maternal and perinatal health
outcomes. The second step was to select,
from the whole population, healthy
pregnant women at low risk of adverse
outcomes.26 This is very different to the
policy of recruiting women from selected
hospitals, which frequently introduces
bias, because women who attend certain
hospitals for pregnancy care may be
different from the overall population of
pregnant womeneparticularly when the
population is served by private and
public hospitals, and recruitment is from
one but not the other.
In the INTERGROWTH-21st project
(Panel 2), all institutions providing
obstetric care in 8 delimited urban areasy FEBRUARY 2018with no or low levels of major, known,
nonmicrobiological contamination,28
were selected to ensure that the study
was population-based. Thus, a strategy
of including delimited geographic areas
where the health, educational, and
nutritional needs of all the inhabitants
are mostly reached is very different to
that of the WHO-sponsored4 and Eunice
Kennedy Shriver National Institute of
Child Health and Human Development
(NICHD)5 fetal studies, which selected a
number of convenient hospitals. This
lack of population-based sampling
means that the sites selected by these 2
studies would have been ineligible for
the INTERGROWTH-21st project.
Healthy pregnant women with a
naturally conceived singleton pregnancy,
who met the individual inclusion
criteria,26 were identified prospectively
in the INTERGROWTH-21st project.
Approximately one third of the healthy
women who met these criteria were
enrolled in the Fetal Growth Longitudi-
nal Study, 1 of the project’s 5 studies. This
is the cohort fromwhich the fetal growth
standards,1 and the standards for: (1)
symphysis-fundal height,29 (2) gesta-
tional weight gain,30 (3) early pregnancy
dating,2 (4) estimated fetal weight
(EFW),3 (5) newborn body composi-
tion,31 and (6) the postnatal growth of
preterm infants were derived,32 as well
as, in 2018, (7) fetal velocity growth
and (8) neurodevelopment at 2 years of
age. These tools are available as
Supplementary Material for clinical use.
Underlying these tools was a series of
systematic reviews of current clinical
practice and development of methodol-
ogies based on a deep understanding of
the issues to arrive at optimal scientific
analytical framework. It should be noted
that there was wide heterogeneity in
methods, tests, and definitions used in
previous studies (Panel 3).
Women were recruited <14 weeks’
gestation, and pregnancies were dated
based on a certain last menstrual period,
but corroborated by ultrasound mea-
surement of the CRL.33 Ultrasound
scans were then performed every 5  1
weeks from the initial dating scan by
dedicated research staff using identical,
midrange ultrasound machines at each
PANEL 2
Different studies of INTERGROWTH-21st project
NCSS Demographic and pregnancy characteristics, birth length,
head circumference, weight and neonatal conditions of all
newborn babies from 8 geographically defined populations
using identical methods and instruments
FGLS A subgroup of NCSS: women who met individual inclusion
criteria from these populations were followed up from<9 wk
through to end of pregnancy; this included serial fetal
ultrasound scans and newborn anthropometry and body
composition
Infant Follow-Up Study All FGLS newborns were then followed up until age 2 y for
growth, health, and development
Preterm Postnatal Follow-Up
Study
All preterm births in FGLS cohort that underwent detailed
regular anthropometry and followed up to age of 2 y
Preterm and Impaired Fetal
Growth Syndromes Study
Nested case-control study including all preterm births as well
as all newborns with impaired fetal growth from NCSS
FGLS, Fetal Growth Longitudinal Study; NCSS, Newborn Cross-Sectional Study.
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standardization procedures,34,35 quality-
control measures,36 and blinding of
measurements.
Moreover, unlike any other longitu-
dinal study of ultrasound in pregnancy,
the infants involved in the fetal growth
standards were followed up for 2 years
after birth, using the same standardized
methods employed in the WHO child
growth standards to measure growth,18
neurodevelopment, auditory process-
ing, and sleep-wake patterns at 2 years of
age.37 We have recently reported that the
fetal growth standards cohort remained
healthy up to 2 years of age, with
adequate growth and motor develop-
ment assessed using WHO tools,15,38
supporting its appropriateness for the
construction of the international fetal
and preterm postnatal growth
standards.17
Evaluating similarities in fetal growth
among populations
Critics of the INTERGROWTH-21st
project often misquote our conclusions
by claiming we believe that all babies
everywhere grow in the same way or
birthweight is the same in general pop-
ulations throughout the world. This is
self-evidently not the case. Rather, we
have demonstrated that measures of fetal
and newborn skeletal growth are similar
across diverse geographical settings
when most of the mothers’ socioeco-
nomic, educational, nutritional, and
health needs are met and environmental
constraints on growth are low.16
Skeletal growth was chosen as the
outcomemeasure to evaluate similarities
in growth based on the WHO recom-
mendation to avoid fat-based indicators,
eg, abdominal circumference (AC),
when comparing populations for the
construction of human growth stan-
dards. This is vitally important for fetal
growth screening in developed countries
with an obesity epidemic, and for those
developing countries in epidemiological
transition.
The specific recommendation39 is to
use markers of skeletal or linear growth
because they are: (1) mostly resistant to
skewing in response to “excessive nutri-
tion”39; (2) normally distributed (unlikefat-related indicators); (3) more pre-
cisely measurable than fat-related in-
dicators; (4) consistent with pediatric
practice worldwide as they were used by
WHO to generate the WHO child
growth standards; and (5) although
responsive to undernutrition or infec-
tion, this is hardly relevant in our healthy
populations.
The comparison to assess similarities
or differences in the WHO MGRS
was based on infant height.18 The cor-
responding measure in fetuses is CRL
(that can be measured reliably until 14
weeks’ gestation) and length at birth;
these showed remarkable similarities
among sites using the 3 analytical ap-
proaches described below. It is difficult
to see that large variation should exist
between these 2 time points, but we
assessed it; as length is not measurable
(due to fetal curling) we used HC as a
skeletal measure between 14 weeks of
gestation and at birth.
Conversely, assessing similarities in
fetal growth among populations by EFW,
a composite calculation from 3 different
fetal anthropometric measurements,
contradicts these physiological concepts;
it also adds considerable error to any
estimation, especially at term. In addi-
tion, fetuses can reach the same EFW
through several permutations of the
equation’s components, which areFEBRUARY 2018 Amclearly not comparable. The continued
use in the literature of an old equation,40
determined using a very small sample,
adds to the confusion, especially as it
includes femur length measures ob-
tained using old ultrasound equipment,
which yields different results to modern
ultrasound machines.41
Many studies have shown that the 95%
confidence interval of the random error
associated with EFW accuracy exceeds
14% of birthweight, which is close to 400
g for the average birthweight at term. In
fact, a systematic review concluded that
“the size of the random errors (of EFW)
remains amajor obstacle to confident use
in clinical practice.”42 Accuracy is even
worse for small and large fetuses for
which growth estimation is clinically
more important. All these are very
important issues when comparing dif-
ferences in EFW values among pop-
ulations, which is why it is much more
logical to compare populations using the
individual skeletal parameters, such as
length and HC separately.
Why not to use AC alone to compare
populations considering that it is asso-
ciated with perinatal outcomes in late
pregnancy? The response, based on the
recommendation of skeletal linear
growth, is that AC is a fat-/tissue-based
measure equivalent to weight. Hence, if a
marker of fat/tissue mass were used toerican Journal of Obstetrics& Gynecology S633
PANEL 3
INTERGROWTH-21st international standards for monitoring growth and
development from early pregnancy to 2 years of age
INTERGROWTH-21st international
standards for:
INTERGROWTH-21st systematic review and
conceptual basis supporting international
standards
First-trimester dating2 Systematic review of charts of pregnancy
dating by fetal crown-rump length11
Late pregnancy dating63 Study design and implementation26
Ultrasound methodology, standardization, and
quality control33-36,64,65
Systematic review of charts of fetal size by
ultrasound21
Systematic review of novel biomarkers for
predicting intrauterine growth restriction and
stillbirths66,67
Systematic review and meta-analysis on
predictive accuracy of cerebroplacental ratio
for adverse perinatal and neurodevelopmental
outcomes in suspected fetal growth
restriction68
Fetal growth by ultrasound1
Estimated fetal weight by ultrasound3
Symphysis-fundal height29
Phenotypic classification of SGA69
Phenotypic classification of preterm birth70
Conceptual issues on preterm birth71-73
Systematic review of novel biomarkers for
prediction of spontaneous preterm birth
phenotype74
Newborn size for gestational age and sex
from 24 wk’ gestation to term55,75
Systematic review of charts of newborn
anthropometry22
Conceptual issues for preterm standards76
Systematic review of preterm postnatal
charts23
Preterm postnatal growth: new paradigm77
Anthropometric protocols, standardization, and
quality-control methods for international
growth standards78,79
Newborn body composition and weight for
length standards31
Preterm postnatal growth based on
international feeding recommendations32
Maternal weight gain during pregnancy30 Systematic review of gestational weight gain
charts80
Postnatal follow-up to age 2 y with
neurodevelopmental assessment to
evaluate appropriateness of population for
creating growth standards17
Systematic review of differential effects of
intrauterine growth restriction on childhood
development81
A simplified multidimensional set of
neurodevelopment assessment tools37
Free e-learning training courses82,83 Evaluation of dissemination activities84,85
SGA, small for gestational age.
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Expert Reviews ajog.orgcompare growth across populations, it
would be observed in the third trimester
of pregnancy that, compared to non-
overweight populations, those in the
midst of the obesity epidemic have
fetuses with larger AC values. This is
observed in one of the NICHD publi-
cations,43 which shows an increase in AC
in overweight women compared to those
of normal weight.
Importantly, in the context of the
NICHD argument, fetal AC changes are
mostly due to liver growth supported byS634 American Journal of Obstetrics& Gynecologa small component of abdominal sub-
cutaneous fat. It is, therefore, very diffi-
cult to understand how the different
ethnic groups they studied can have dif-
ferential, genetically driven, liver growth
during the second part of pregnancy.
Why outcome measures should be
masked
It is a basic research principle across
all biological subjects that any
outcome measures being obtained,
especially by medical observers,y FEBRUARY 2018should be masked, as prior knowledge
or real-time plotting by the
operator can strongly influence
their measurement. Prior knowledge
increases the risk of bias in favor of
the hypothesis under investigation,
which certainly applies to ultrasound
measurements, where the operator can
influence the values obtained. In the
INTERGROWTH-21st project, the
identical ultrasound machines used at
every site were adapted to enable
measurements to be taken in a
blinded fashion; this has not been the
case in all other fetal studies
despite the well-recognized potential
for bias.
Which is the most appropriate
analytical strategy?
Data from studies combining pop-
ulations should be analyzed in 2 steps:
first, by evaluating the similarities
among sites (or ethnic groups in the case
of the NICHD fetal study) and second by
estimating the centiles. For the first step,
we followed the WHO recommended
strategy for the construction of growth
standards based on 3 complementary
methods after the literature was sys-
tematically reviewed.44 In contrast the
WHO-sponsored study on fetal growth
used a P value-multiple testingebased
strategy; while the NICHD study was
designed to create separate standards for
the 4 ethnic groups, so the issue of
potential pooling was not assessed. In the
NICHD study, judgements of differences
were again based on a P value and
although the potential clinical signifi-
cance was assessed, this was done a
posteriori rather than as a judgement on
whether pooling should take place or
not. This is another core element
that differentiates these 3 publications
(Panel 1).
It is obvious that statistical signifi-
cance is not the same as clinical signifi-
cance and that small differences, well
within the measurement error of ultra-
sound equipment, may achieve statistical
significance in a study with a large
sample size. For example, in a study than
included women enrolled in the NICHD
study,43 the median femur length was 0.8
mm longer and the median humerus
FIGURE 1
Fetal HC growth in the INTERGROWTH-21st, NICHD, and WHO-sponsored
studies are remarkably similar
Standardized study discrepancy (SSD) of fitted fetal head circumference. Study-specific means were
obtained as unweighted average of values from published charts (by gestational week) for 5
gestational age intervals. SSD was calculated as difference between individual study mean and mean
of all studies combined, divided by Fetal Growth Longitudinal Study (FGLS) adjusted SD,7 at each
gestational age interval. World Health Organizationesponsored study15 (gray circles); FGLS of
INTERGROWTH-21st20 (green circles); and Eunice Kennedy Shriver National Institute of Child Health
and Human Development fetal growth studies19: white (red circles), black (squares), Hispanic (tri-
angles), Asian (diamonds).
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2320 nonobese women (in context the
lengths were 71.0 vs 70.2 mm; and 62.2
vs 61.6 mm, respectively). The differ-
ences are judged to be statistically sig-
nificant because the P values are .01 and
.03, respectively, but are of minimal
clinical relevance and well within mea-
surement error, whichmay in any case be
higher in obese women.
Therefore, the clinically relevant dif-
ference should be defined a priori, and
P values have no place in deciding
whether these differences are clinically
meaningful. Furthermore, the use
of multiple testing for comparing indi-
vidual populations against each other is
an irrelevance, as it was never suggested
that fetuses from one site, eg, in India,
should be evaluated using charts from
another site, eg, in Brazil or the United
States. What is recommended is to create
international standards by combining
data from prescriptive populations
against which all samples are compared.
Standardization of tools and measures is
a central practice not only in biology and
medicine, but also in all fields of science
and even the arts.
Hence, the INTERGROWTH-21st
project set up its a priori conditions on
whether to pool the data sets based on
the WHO internationally accepted
3-component strategy used for the WHO
child growth standards. The clinically
relevant difference was also defined a
priori using the appropriate, recom-
mended outcomemeasure for evaluating
growth across populations. We are un-
sure why the investigators of the WHO-
sponsored study, who must have been
aware of the WHO expert committee
recommendations, did not follow them
or use even the most practical analytical
method, namely sensitivity analysis. This
is relevant because they advocated
pooling their data, despite calling them
different, without conducting a standard
sensitivity analysis.4
To conduct such an evaluation, we
used the SD of the all sites’ combined
value of fat-free measures as the de-
nominator for the standardization pro-
cess,45 following WHO previous work.18
For fetal growth, this involved values for
both CRL and HC obtained from themean of 3 highly standardized measures
of the same individual at each visit.When
this protocol was applied to the
INTERGROWTH-21st fetal growth data,
which constituted 128 comparisons of
fetal CRL and HC from early pregnancy
to term, as well as birth length, only 1
value was marginally outside (standard-
ized study discrepancy e0.58)16 the pri-
mary cut-off of 0.5 SD, recommended
by the WHO MGRS group.44
A key question is: what would the 2
recently published fetal studies’ results
have been had the investigators followed
the same analytical strategy as the WHO
MGRS group?18,44 To explore this ques-
tion, we have produced the matchingFEBRUARY 2018 Amanalyses, which the authors did not
perform. Figure 1 shows that, when the
results of the 2 studies are combined, the
differences among all the study sites are
well within the limits established a priori
for fetal skeletal measures, in agreement
with the INTERGROWTH-21st previous
publications. This was to be expected
because the actual 50th centile of fetal
HC according to gestational age was
almost identical across these populations
(Figure 2).
Race/ethnicity is not a biological
factor influencing fetal growth
Several groups have suggested adjusting
fetal growth charts for maternalerican Journal of Obstetrics& Gynecology S635
FIGURE 2
Comparison of INTERGROWTH-21st, NICHD, and WHO-sponsored studies
show limited discrepancies in fetal HC
Comparison of fitted 5th, 50th, and 95th centiles of fetal head circumference. World Health
Organizationesponsored study15 (gray solid lines); Fetal Growth Longitudinal Study of
INTERGROWTH-21st20 (green solid lines); and Eunice Kennedy Shriver National Institute of Child
Health and Human Development fetal growth studies19: white (solid red lines), black (dashed red
lines), Hispanic (dash-dot red lines), Asian (dot-dot-dash red lines).
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reported race/ethnicity. However, the
use of race/ethnicity is problematic in
most nonisolated populations because
of large ancestral admixture due to
global migration, invasions, and other
population movements. There are also at
least 116 definitions of self-reported
race/ethnicity in the biomedical
literature.46
The alternative, more compelling view
is that race/ethnicity is simply a social
construct that represents a proxy for SES,
education, and social class background,
which is related to many poor health andS636 American Journal of Obstetrics& Gynecologsocial outcomes, eg, stillbirth and47
maternal mortality.48 In the NICHD
fetal study, which proposed using
different charts in the United States for
“non-Hispanic whites, non-Hispanic
blacks, Hispanics, and Asian/Pacific is-
landers,” differences seen in fetal growth
between these groups must be taken in
the context of the enormous differences
in annual family income and other SES
markers such as marital status, educa-
tion, and private health insurance. In
addition, the fact that SES and race/
ethnicity often merge is frequently
ignored when making adjustments and,y FEBRUARY 2018in our view, presents a dangerous
precedent.
There is also no scientific evidence
that self-reported race/ethnicity is bio-
logically or genetically related to fetal
growth. Actually, all the genetic evi-
dence across global populations dem-
onstrates the opposite, ie, only a very
small proportion of human linear
growth is related to genetic factors. As
measured in observational studies, the
differences between geographic loca-
tions cannot explain >10% of the
variability in human length. In addi-
tion, strong genetic evidence from a
multiancestry, genomewide association
study meta-analysis involving 153,781
participants identified as many as 60
genetic loci associated with birthweight
(as a proxy for fetal growth) with only
15% of the variance in birthweight be-
ing captured by assays of fetal genetic
variation.49
Furthermore, in any country, such as
the United States, whose inhabitants
often have mixed ancestral backgrounds,
it is impossible to see how racial/ethnic
classification could even be imple-
mented during the course of routine
antenatal care, especially as some of the
groupings are hardly scientific. For
example, based on US census practice,
“Asian” includes Chinese, Japanese,
South Indian, and Pacific Islander
groups. Black American and African
Americans are often grouped together,
although health behaviors between
African-born and American-born blacks
are acknowledged to be different.50
Hispanics are presumably an ethnic
group of European origin with (or
without) native-American mixing? In
fact, the infeasibility and inaccuracy of
defining race/ethnicity in contemporary
multicultural settings was recently
demonstrated in an Australian study,51
using the gestation-related optimal
weight customized charts.52 In a sense,
however, the impracticality is an irrele-
vance because racial-/ethnic-specific
charts are indefensible on biological
grounds.53
Interestingly, one of the quotations
often used to justify having racial/ethnic
fetal growth charts is from a paper by
Bogin and Varela-Silva54 in 2010,
FIGURE 3
Local references artificially “fix” the rate of SGA at 10%; international
standards show different SGA rates as expected
Rates of small for gestational age (SGA) from 16 prospective cohorts of newborns from 10 low- and
middle-income countries. Empty columns show prevalence of SGA using INTERGROWTH-21st
standards,47 compared with effect of using fixed cut-off SGA rate of 10% that would result from
using local reference charts (black columns). Data from Kozuki et al.56
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provided rather different views. They
stated that “even if specific genotypes are
discovered, their direct contribution to
normal ethnic (so-called ‘racial’) varia-
tion in human body shape may be rela-
tively small. At 40 weeks’ gestation,
fetuses identified as African-Americans
have, on average, relatively longer legs
than fetuses identified as European-
Americans. But the difference, as
measured by (total length/CRL) is less
than 1%.”54 Such views and those of
many other scientists accord with the
belief that race/ethnicity is a social
rather than a biological construct and a
form of categorization that is ill-defined,
especially in populations that have
experienced high ancestral admixture
rates.
The rationale for adjusting for other
factors is similarly questionable. For
example, parity (nulliparous women
have on average smaller fetuses, but are
also at higher risk of other features of
placental insufficiency such as pre-
eclampsia) or maternal weight, highly
dependent on overnutrition and under-
nutrition, are questionable and are not
unchanging characteristics. Even char-
acteristics that do not change within an
individual’s lifeesuch as maternal
heighteare highly changeable within
just a few generations and therefore
nutritionally dependent.
Implications for screening in the
general pregnant population: local
charts vs international standards
It is suggested that fetal growth charts for
EFWand common ultrasound biometric
measures >14 weeks’ gestation “reveal a
wide range of variation in human fetal
growth across different parts of the
world” with “significant differences in
fetal growth between countries.”4 It is
hard to understand how borders be-
tween countries, often drawn on maps
by colonial powers, can possibly have a
biological influence on human growth,
nor how heterogeneity within pop-
ulations can be negated by national
boundaries.
So, what happens if “population-
specific high-quality reference intervals”
for each population are created?4 Apartfrom the obvious hindrance of having
to create hundreds of high-quality
reference intervals for countries, re-
gions, cities, villages, or hospitals, this
approach is entirely fallacious. If a
reference range is created for each re-
gion, by definition 10% of fetuses and
newborns will be <10th centile of each
local chart, and 10% will be >90th
centile. Pretending that a uniform pro-
portion of the population of fetuses
across the world have the same degree of
growth aberration is nonsensical and
entirely at odds with differences in rates
of maternal obesity, diabetes, pre-
eclampsia, malnutrition, and infectious
diseases. “Fixing” charts in this way
would mean that no country, region, or
city would have an excess of underweight
or overweight babiesea concept so far
removed from common sense and bio-
logical principles as to be difficult to
comprehend.
This has been unequivocally demon-
strated in 2 recently published reanalyses
of data from low- and middle-income
countries, using a birthweight <10th
centile of the INTERGROWTH-21stFEBRUARY 2018 Amnewborn size for gestational age/sex
standards55 as the definition of SGA. In
the first study, the overall SGA preva-
lence was 24% among 16 birth cohorts56;
in the second, the rate was 19% among
14 cohorts.12 Of course, the prevalence
would have been 10% had local charts
been used (Figure 3).
At the other end of the health spec-
trum, we have previously shown that in
England in 2011 through 2012 there
were, as expected, 11% live singleton
babies born >33 weeks’ gestation>90th
centile if local charts of birthweight for
gestational age are used.57 However,
when INTERGROWTH-21st interna-
tional standards are used for the cut-off
point,55 the rate of overweight new-
borns increased to 19% overall, which
matches the high prevalence of obesity in
pregnant women and children in En-
gland (Figure 4).58,59
An additional practical issue specific
to theWHO-sponsored reference charts,
in terms of their global use for screening,
is that they are sex-specific and their
use presupposes prenatal sex determi-
nation. Even if we assume that theerican Journal of Obstetrics& Gynecology S637
FIGURE 4
Higher rates of LGA newborns by international standards than a local
reference, matching the high prevalence of overweight in the general
population
Prevalence of large for gestational age (LGA) (>90th birthweight centile) newborns in England in
2011 through 2012. Estimated prevalence of LGA using British 1990 growth reference centiles49
(blue line) or INTERGROWTH-21st newborn size at birth standards47 (green line). The horizontal
dotted line represents the expected (by definition) 10% of newborns above the 90th centile of a local
reference chart.
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ents want to know the fetal sex, the
practice is banned in some countries.60
Conclusions
The WHO child growth standards15 are
now used in nearly every country in
the world to measure the growth of
children from 0-5 years of age.61 The
INTERGROWTH-21st project was
designed using exactly the same pre-
scriptive approach as the WHO MGRS,
ie, based on WHO recommendations
regarding the construction of human
growth standards.24 The charts gener-
ated by the WHO MGRS and
INTERGROWTH-21st project integrate
perfectly so that, for the first time in
history, a uniform method exists for
monitoring linear growth from the
“womb to classroom.”62
Many of the clinical tools derived
from the same healthy cohort as theS638 American Journal of Obstetrics& Gynecologfetal growth standards are now being
used routinely around the world, eg,
the preterm postnatal growth standards,
which were adopted by both WHO13
and the Centers for Disease Control
and Prevention14 in the context of the
Zika epidemic. These and other stan-
dards derived from the same cohort,
eg, for measuring symphysis-fundal
height29 and maternal weight gain,30
as well as tools for estimating gesta-
tional age in early2 and late63 pregnancy
have had >65,000 downloads from our
website (data up until Nov. 21, 2017)
and close to 10,000 health care pro-
fessionals have been trained using
INTERGROWTH-21st e-learning
modules.
There is no scientific rationale for
using local references instead of stan-
dards in clinical practice, and custom-
ization based on the color of a mother’s
skin, the sex of her fetus, or hery FEBRUARY 2018nationality is unacceptable in the 21st
century. Furthermore, classifying any of
the 23.3 million infants born SGA in
low- to middle-income countries ac-
cording to the INTERGROWTH-21st
newborn size standards for gestational
age/sex12 as normally grown by local
charts could potentially deprive them of
their right to better health care given that
most are SGA because of impaired fetal
growth due to malnutrition and/or in-
fectious diseases. -
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